Abveris is an antibody discovery biotech company providing contract research services for biopharma companies of various sizes. Over the past two years, we have seen exceptional sales growth, which depends heavily upon the continuation of successful relationships with our customers. We are searching for a full-time Antibody Discovery Inside Sales/Marketing Manager to join our team and continue to develop strong customer relationships. The Inside Sales/Marketing Manager will work closely with the Director of Antibody Discovery Operations to coordinate custom antibody discovery projects from early project design to final deliverables. In this role, the Inside Sales/Marketing Manager will act as the liaison between customers and our laboratory scientists and will therefore have a high level of involvement in alliance management at Abveris. A major part of the role will involve coordination of multiple custom antibody development projects, including direct management of a portfolio of projects, customer communications and interaction with scientific teams. A successful candidate will be highly organized with a keen eye for detail. This job is ideal for scientists looking to transition out of the lab and into the business side of antibody discovery.
Job responsibilities to include:
Abveris is a growing CRO/biotech that focuses on discovery of novel monoclonal antibodies. Our customers include some of the largest biopharma companies worldwide and many of the hottest new companies in biotech. We provide high quality, rapid antibody discovery services primarily for potential therapeutics and critical reagent development. Abveris’s differentiating technology is a proprietary, auto-immune, engineered murine discovery platform that delivers antibodies against tough-to-target immunogens, quickly.
Abveris is privately owned and proud to provide an enjoyable work environment. We have a small company, entrepreneurial spirit and enjoy going the extra mile to deliver the best possible outcome for our customers.
We have been in business since 2014 and already count dozens of major and start-up biotherapeutics companies as our delighted customers